Stay updated on Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLatest version adds a Study Status entry dated 2026-02-10 and records revision v3.4.2. It also removes a government funding notice from the page.SummaryDifference0.8%

- Check20 days agoChange DetectedAdded a government funding notice and a new site revision label (v3.4.1); removed the previous revision label (v3.4.0).SummaryDifference0.5%

- Check28 days agoChange DetectedUI updates include a 'Show glossary' option, color-coded change highlights (green for additions, red for deletions), and a revision label showing v3.4.0 instead of v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history. This reflects internal versioning updates and does not affect the study details or user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedAn entry for Revision: v3.3.2 was added to the history and Revision: v3.2.0 was removed. This reflects versioning updates rather than changes to study data or page content.SummaryDifference0.1%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.